These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [(18)F]FDG in childhood lymphoma: clinical utility and impact on management. Montravers F; McNamara D; Landman-Parker J; Grahek D; Kerrou K; Younsi N; Wioland M; Leverger G; Talbot JN Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1155-65. PubMed ID: 12192560 [TBL] [Abstract][Full Text] [Related]
9. Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography. Stumpe KD; Urbinelli M; Steinert HC; Glanzmann C; Buck A; von Schulthess GK Eur J Nucl Med; 1998 Jul; 25(7):721-8. PubMed ID: 9662594 [TBL] [Abstract][Full Text] [Related]
10. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
11. Frequent impact of [18F]fluorodeoxyglucose positron emission tomography on the staging and management of patients with indolent non-Hodgkin's lymphoma. Blum RH; Seymour JF; Wirth A; MacManus M; Hicks RJ Clin Lymphoma; 2003 Jun; 4(1):43-9. PubMed ID: 12837154 [TBL] [Abstract][Full Text] [Related]
12. Role of attenuation correction for fluorine-18 fluorodeoxyglucose positron emission tomography in the primary staging of malignant lymphoma. Kotzerke J; Guhlmann A; Moog F; Frickhofen N; Reske SN Eur J Nucl Med; 1999 Jan; 26(1):31-8. PubMed ID: 9933659 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods? Spaepen K; Stroobants S; Dupont P; Van Steenweghen S; Thomas J; Vandenberghe P; Vanuytsel L; Bormans G; Balzarini J; De Wolf-Peeters C; Mortelmans L; Verhoef G J Clin Oncol; 2001 Jan; 19(2):414-9. PubMed ID: 11208833 [TBL] [Abstract][Full Text] [Related]
14. Fluorine-18 fluorodeoxyglucose PET-CT for extranodal staging of non-Hodgkin and Hodgkin lymphoma. Ömür Ö; Baran Y; Oral A; Ceylan Y Diagn Interv Radiol; 2014; 20(2):185-92. PubMed ID: 24412817 [TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL). Jerusalem G; Beguin Y; Najjar F; Hustinx R; Fassotte MF; Rigo P; Fillet G Ann Oncol; 2001 Jun; 12(6):825-30. PubMed ID: 11484959 [TBL] [Abstract][Full Text] [Related]
16. [Clinical value of FDG PET using coincident gamma cameras in staging and restaging of malignant lymphoma--compared with convenitonal diagnostic methods]. Pichler R; Maschek W; Hatzl-Griesenhofer M; Huber H; Wimmer G; Wahl G; Fridrik M Nuklearmedizin; 2000 Sep; 39(6):166-73. PubMed ID: 11057408 [TBL] [Abstract][Full Text] [Related]
17. Staging, response to therapy, and restaging of lymphomas with 18F-FDG PET. Altamirano J; Esparza JR; de la Garza Salazar J; Calvo PS; Vera SR; Chalapud Revelo JR; Estrada G Arch Med Res; 2008 Jan; 39(1):69-77. PubMed ID: 18067998 [TBL] [Abstract][Full Text] [Related]
18. Whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin's disease. Bangerter M; Moog F; Buchmann I; Kotzerke J; Griesshammer M; Hafner M; Elsner K; Frickhofen N; Reske SN; Bergmann L Ann Oncol; 1998 Oct; 9(10):1117-22. PubMed ID: 9834825 [TBL] [Abstract][Full Text] [Related]
19. Whole-body hybrid PET with 18F-FDG in the staging of non-Hodgkin's lymphoma. Tatsumi M; Kitayama H; Sugahara H; Tokita N; Nakamura H; Kanakura Y; Nishimura T J Nucl Med; 2001 Apr; 42(4):601-8. PubMed ID: 11337549 [TBL] [Abstract][Full Text] [Related]
20. Whole-body 18F-FDG PET for the evaluation of patients with Hodgkin's disease and non-Hodgkin's lymphoma. Jerusalem G; Warland V; Najjar F; Paulus P; Fassotte MF; Fillet G; Rigo P Nucl Med Commun; 1999 Jan; 20(1):13-20. PubMed ID: 9949408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]